AH

Topic 10) Infectious Disease (AS)

Topic 10: Infectious Disease

10.1 Infectious Diseases

Understand the nature, transmission, and impact of infectious diseases

🔹 Definition & General Understanding
  • Infectious disease: A disease caused by a pathogen that can be transmitted from one host to another.

  • Contrast with non-infectious diseases (e.g., genetic, autoimmune, or lifestyle-related).

🔹 Common Pathogens
  • Bacteria

  • Viruses

  • Fungi

  • Protoctists (protozoa)

🔹 Global Examples of Infectious Diseases
  • Cholera – caused by Vibrio cholerae

  • Malaria – caused by Plasmodium spp. (protoctist)

  • Tuberculosis (TB) – caused by Mycobacterium tuberculosis

  • HIV/AIDS – caused by Human Immunodeficiency Virus (HIV)

  • Measles – caused by measles virus

  • Smallpox – caused by Variola virus (eradicated)

🔹 Cholera
  • Causative agent: Vibrio cholerae

  • Mode of transmission: Ingestion of contaminated water or food

  • Symptoms: Severe diarrhea, dehydration

  • Control/prevention:

    • Safe drinking water

    • Improved sanitation

    • Oral rehydration therapy (ORT)

    • Vaccination

🔹 Malaria
  • Causative agent: Plasmodium falciparum (most severe), P. vivax, etc.

  • Vector: Female Anopheles mosquito (biological vector)

  • Life cycle features:

    • Human host: liver and red blood cells

    • Mosquito vector: sexual reproduction

  • Symptoms: Fever, chills, anemia, organ damage

  • Control/prevention:

    • Insecticide-treated nets (ITNs)

    • Indoor residual spraying

    • Draining stagnant water

    • Antimalarial drugs (e.g., artemisinin)

🔹 Tuberculosis (TB)
  • Causative agent: Mycobacterium tuberculosis

  • Transmission: Airborne droplets (coughing, sneezing)

  • Symptoms: Persistent cough, chest pain, blood in sputum, weight loss

  • Latent vs Active TB

  • Control/prevention:

    • BCG vaccination

    • Early detection and treatment

    • Antibiotics (e.g., isoniazid, rifampicin)

    • DOTS program (Directly Observed Therapy, Short-course)

🔹 HIV/AIDS
  • Causative agent: HIV (Human Immunodeficiency Virus)

  • Transmission:

    • Sexual contact

    • Blood-to-blood contact

    • From mother to child (during birth or breastfeeding)

  • Effect on immune system:

    • Targets CD4+ T-helper cells

    • Reduces immunity → leads to AIDS

  • Symptoms:

    • Early: flu-like symptoms

    • Later: opportunistic infections (e.g., TB, pneumonia)

  • Control/prevention:

    • Safe sex practices

    • Blood screening

    • Antiretroviral therapy (ART)

    • Education and awareness programs


10.2 Antibiotics

Understand the role and challenges of antibiotics in treating infectious diseases

🔹 Definition and Action
  • Antibiotic: A substance produced by microorganisms that kills or inhibits the growth of bacteria.

  • Types of action:

    • Bactericidal: Kills bacteria (e.g., penicillin)

    • Bacteriostatic: Inhibits bacterial growth (e.g., tetracycline)

🔹 Mechanism of Antibiotics
  • Penicillin:

    • Inhibits synthesis of bacterial cell walls

    • Effective against Gram-positive bacteria

  • Other mechanisms:

    • Inhibition of protein synthesis

    • Disruption of cell membrane

    • Inhibition of DNA/RNA synthesis

    • Inhibition of metabolic pathways (e.g., folic acid synthesis)

🔹 Limitations of Antibiotics
  • Ineffective against viruses:

    • Viruses lack cell structures targeted by antibiotics

    • Viruses reproduce inside host cells

🔹 Antibiotic Resistance
  • Development:

    • Natural selection: Resistant mutants survive and reproduce

    • Misuse and overuse of antibiotics (e.g., not completing treatment, using for viral infections)

  • Mechanisms:

    • Enzyme production (e.g., β-lactamase breaks down penicillin)

    • Altered target sites

    • Increased efflux or decreased uptake

  • Examples:

    • MRSA (Methicillin-resistant Staphylococcus aureus)

    • MDR-TB (Multi-drug resistant tuberculosis)

🔹 Controlling Resistance
  • Prudent use of antibiotics

  • Educating public and professionals

  • Infection control in hospitals

  • Development of new antibiotics

  • Global surveillance and regulation